Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

Related Citations for PubMed (Select 22681766)

1.

U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.

Borders-Hemphill V, Mosholder A.

Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.

PMID:
22681766
2.

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.

Influenza Other Respir Viruses. 2012 Nov;6(6):e143-51. doi: 10.1111/j.1750-2659.2012.00390.x. Epub 2012 Jun 11.

PMID:
22687171
3.

Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.

Lackenby A, Elliot AJ, Powers C, Andrews N, Ellis J, Bermingham A, Thompson C, Galiano M, Large S, Durnall H, Fleming D, Smith G, Zambon M.

J Antimicrob Chemother. 2013 Oct;68(10):2324-31. doi: 10.1093/jac/dkt203. Epub 2013 Jun 12.

4.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

5.

Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.

Chowell G, Viboud C, Simonsen L, Miller MA, Echevarría-Zuno S, González-León M, Aburto VH.

BMC Infect Dis. 2012 Apr 20;12:97.

6.

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B.

Antiviral Res. 2012 Nov;96(2):130-7. doi: 10.1016/j.antiviral.2012.08.002. Epub 2012 Aug 14.

PMID:
22909899
7.

Value of pharmacy-based influenza surveillance - Ontario, Canada, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 24;62(20):401-4.

8.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
9.

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.

Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR.

Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:82-6. doi: 10.1111/irv.12092. Review.

PMID:
24034490
10.

[New influenza A (H1N1): advised indication and prescription of antiviral drugs].

van den Wijngaard CC, van Steenbergen JE, van der Sande MA, Koopmans MP.

Ned Tijdschr Geneeskd. 2009;153:A1053. Dutch.

PMID:
19857317
11.

Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.

Duwe SC, Wedde M, Birkner P, Schweiger B.

Antiviral Res. 2011 Jan;89(1):115-8. doi: 10.1016/j.antiviral.2010.11.001. Epub 2010 Nov 9.

PMID:
21070812
12.

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.

Atkins CY, Patel A, Taylor TH Jr, Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI.

Emerg Infect Dis. 2011 Sep;17(9):1591-8. doi: 10.3201/eid1709.110295.

13.

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.

Ledesma J, Vicente D, Pozo F, Cilla G, Castro SP, Fernández JS, Ruiz MP, Navarro JM, Galán JC, Fernández M, Reina J, Larrauri A, Cuevas MT, Casas I, Breña PP; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.

PMID:
21592854
14.

Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.

Xiao Y, Patel Z, Fiddler A, Yuan L, Delvin ME, Fisman DN.

Influenza Other Respir Viruses. 2013 Nov;7(6):1409-15. doi: 10.1111/irv.12141. Epub 2013 Jul 23.

PMID:
23879801
15.

Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.

Petersen E, Keld DB, Ellermann-Eriksen S, Gubbels S, Ilkjær S, Jensen-Fangel S, Lindskov C.

Scand J Infect Dis. 2011 Jul;43(6-7):495-503. doi: 10.3109/00365548.2011.556144. Epub 2011 Feb 10.

PMID:
21309638
16.

Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008-2010.

Suda KJ, Regen SM, Lee TA, Easterling JL, Hunkler RJ, Danziger LH.

Int J Antimicrob Agents. 2014 Mar;43(3):279-83. doi: 10.1016/j.ijantimicag.2013.10.025. Epub 2013 Dec 1.

PMID:
24373618
17.

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.

Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, Waters C, Moore Z, Sleeman K, Okomo-Adhiambo M, Marshall SA, St George K, Pan CY, LaPlante JM, Klimov A, Fry AM.

Emerg Infect Dis. 2011 Feb;17(2):255-7. doi: 10.3201/eid1702.101724.

18.

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.

Hernandez JE, Grainger J, Simonsen L, Collis P, Edelman L, Sheridan WP.

Influenza Other Respir Viruses. 2012 Sep;6(5):305-8. doi: 10.1111/j.1750-2659.2011.00303.x. Epub 2011 Nov 16.

PMID:
22085222
19.

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.

Liu CH, Wang JL, Su CP, Chuang JH, Chang CH, Lai MS.

BMC Public Health. 2013 Jul 12;13:646. doi: 10.1186/1471-2458-13-646.

20.

Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.

Marra F, Chong M, Henry B, Patrick DM, Kendall P.

J Antimicrob Chemother. 2014 May;69(5):1397-406. doi: 10.1093/jac/dkt496. Epub 2013 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk